Quick Answer
Inogen Inc reported R&D Expense of $19.40 million for fiscal year 2025.
Inogen Inc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $19.40M | -10.2% |
| 2024 | $21.61M | +3.7% |
| 2023 | $20.84M | -5.0% |
| 2022 | $21.94M | +32.4% |
| 2021 | $16.58M | +17.7% |
| 2020 | $14.08M | +49.8% |
| 2019 | $9.40M | +33.7% |
| 2018 | $7.03M | +32.3% |
| 2017 | $5.31M | +3.9% |
| 2016 | $5.11M | +22.3% |
| 2015 | $4.18M | +40.4% |
| 2014 | $2.98M | +24.1% |
| 2013 | $2.40M | +6.0% |
| 2012 | $2.26M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.84M | +37.6% | -7.1% |
| June 30, 2025 | $5.21M | -7.2% | +29.1% |
| March 31, 2025 | $4.03M | -38.7% | +14.7% |
| September 30, 2024 | $3.52M | -21.6% | -37.4% |
| June 30, 2024 | $5.62M | +30.8% | -14.6% |
| March 31, 2024 | $6.58M | +23.1% | +46.5% |
| September 30, 2023 | $4.49M | -2.0% | +4.6% |
| June 30, 2023 | $4.29M | -29.2% | -19.7% |
- Inogen Inc showed a decrease of -10.2% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, Inogen Inc’s r&d expense has grown by 757.6% (from $2.26 million to $19.40 million).
- The most recent figure is from Inogen Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: